payday loans
payday loans
Skip to content

Accueil FMC Bibliographie
Listing des derniers articles parus

Dans cette rubrique on vous propose une revue de la littérature à travers une sélection d'abstracts d'articles originaux.
On essaiera de vous tenir informé des dernières nouveautés de recherche en matière de Pneumologie. On ne vous fournit que le résumé de l'article et le lien correspondant, pour accéder à l'article en full text vous devez être inscrits à la revue correspondante.
Cliquez ici pour consulter la liste des revues de Pneumologie disponibles en libre accès.

Filtrer par titres     Affichage # 
# Titre de l'article
251 DNA damage and repair capacity in lymphocyte of chronic obstructive pulmonary diseases patients during physical exercise with oxygen supplementation
252 Physiological Mechanisms of Airways Hyperresponsiveness in Obese Asthma.
253 National Institutes of Health (NIH) Stroke Scale
254 Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis.
255 Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.
256 Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?
257 Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
258 Chemotherapy for Tuberculous Meningitis
259 New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group.
260 Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
261 Lung tumors, COPD and immune response: is epigenetics the bottom line?
262 Percutaneous Rotational Pulmonary Thrombectomy
263 Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis.
264 Environmental Microbial Exposure and Protection against Asthma
265 Local lung deposition of ultrafine particles in healthy adults: experimental results and theoretical predictions.
266 Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis
267 Lung cancer: a rare indication for, but frequent complication after lung transplantation.
268 Lung sarcoidosis: Clinical features and therapeutic issues.
269 Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future Direction.
270 Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
271 Periostin: The bone and beyond.
272 Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways.
273 Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
274 Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
275 FDG-PET parameters predicting mediastinal malignancy in lung cancer.
276 Lung-gut crosstalk: evidence, mechanisms and implications for the mucosal inflammatory diseases.
277 Genetic Modification of the Lung Directed Toward Treatment of Human Disease.
278 Allergen immunotherapy for insect venom allergy: protocol for a systematic review.
279 Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?
280 Molecular testing patterns in metastatic non-small cell lung cancer.
281 New Therapies for Asthma and COPD.
282 Indoor microbial communities: Influence on asthma severity in atopic and nonatopic children
283 How Do Dual Long-acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
284 International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics
285 Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges.
286 Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
287 Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep.
288 Sublingual or subcutaneous immunotherapy for allergic rhinitis?
289 Epigenetic dysfunctional diseases and therapy for infection and inflammation.
290 The microbial environment and its influence on asthma prevention in early life
291 Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?
292 Air pollution and chronic airway diseases: What should people know and do?
293 Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
294 What is the quality of smoking cessation advice in guidelines of tobacco-related diseases?
295 Severe asthma exists despite suppressed tissue inflammation: findings of the U-BIOPRED study
296 Current methods to diagnose small airways disease in patients with COPD.
297 First evaluation of QuantiFERON-TB Gold Plus performance in contact screening
298 Olfactory deposition of inhaled nanoparticles in humans.
299 Mast cells are associated with exacerbations and eosinophilia in children with severe asthma
300 Particle retention by respiratory epithelial cells is associated with persistent biological effect.
 
<< Début < Précédent 1 2 3 4 5 6 7 8 9 10 Suivant > Fin >>
Page 6 sur 198

find-us-on-facebook-2

United4LungHealth

image001

waw15-clr-logo2

WCD2015



PubMed Logo
Word

 To: 

Langtolang Dictionary

CNP2014Ebook

50x50_firefoxsafari_iconGchrome


Notre site est optimisé pour les Navigateurs suivants : Firefox, Safari et Google Chrome. Cliquez sur l'un des logos ci-dessus pour le télécharger et l'installer gratuitement.

Tabac

Accueil FMC Bibliographie Top